Device Week, 6 November 2020 – Q3 Earnings Results,USPSTF Recommendations Lowers Colon Screening Age
Citeline Podcasts - A podcast by Citeline
Categories:
In this week’s podcast, Medtech Insight's managing editor Marion Webb discusses how the US Preventive Services Task Force’s recommendations to lower colon screening to age 45 may impact Exact Sciences’ Cologuard stool test. Deputy editor Reed Miller highlights third-quarter results of Stryker, Boston Science and Edwards Lifesciences. Listen to the podcast via the player below: Stryker Sees ‘V-Shape’ Recovery In Third Quarter Boston Scientific Exceeds Wall Street’s Expectations In Q3 Edwards Returns To Growth In The Third Quarter USPSTF Recommendations For Colon Cancer Screening At Age 45 Could Give Cologuard A Boost For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode:
